When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

The U.S. Food and Drug Administration proposed on Monday a new framework to speed approvals of personalized treatments for ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

"Disappointing" trial results, but some researchers remain hopeful ...

Subscribe to The Post Most newsletter for the most important and interesting stories from. By now, you’ve probably read the ...

Divergence in the post-progression interval suggests disparities may concentrate in subsequent-line therapy, surveillance, supportive care, or access to timely interventions outside trial ...

This is a shame, because regular exercise is really beneficial. It can control high blood pressure, improve mental health and reduce falls among older adults. A review of 187 randomized controlled ...

Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...

FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.

Announced positive topline results from TX45 Phase 1b acute hemodynamic clinical trial in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction ("PH-HFrEF") in ...